Sample collection and case definitions

KS Katherine J. Siddle
LK Lydia A. Krasilnikova
GM Gage K. Moreno
SS Stephen F. Schaffner
JV Johanna Vostok
NF Nicholas A. Fitzgerald
JL Jacob E. Lemieux
NB Nikolaos Barkas
CL Christine Loreth
IS Ivan Specht
CT Christopher H. Tomkins-Tinch
JP Jillian S. Paull
BS Beau Schaeffer
BT Bradford P. Taylor
BL Bryn Loftness
HJ Hillary Johnson
PS Petra L. Schubert
HS Hanna M. Shephard
MD Matthew Doucette
TF Timelia Fink
AL Andrew S. Lang
SB Stephanie Baez
JB John Beauchamp
SH Scott Hennigan
EB Erika Buzby
SA Stephanie Ash
JB Jessica Brown
SC Selina Clancy
SC Seana Cofsky
LG Luc Gagne
JH Joshua Hall
RH Rachel Harrington
GG Gabrielle L. Gionet
KD Katherine C. DeRuff
MV Megan E. Vodzak
GA Gordon C. Adams
SD Sabrina T. Dobbins
SS Sarah D. Slack
SR Steven K. Reilly
LA Lisa M. Anderson
MC Michelle C. Cipicchio
MD Matthew T. DeFelice
JG Jonna L. Grimsby
SA Scott E. Anderson
BB Brendan S. Blumenstiel
JM James C. Meldrim
HR Heather M. Rooke
GV Gina Vicente
NS Natasha L. Smith
KM Katelyn S. Messer
request Request a Protocol
ask Ask a question
Favorite

State and local authorities identified cases linked to the Provincetown outbreak using travel history and exposure data from the state COVID-19 surveillance system and follow-up case investigation. A primary outbreak-associated case was defined as receipt of a positive SARS-CoV-2 test result (nucleic acid amplification test or antigen test) ≤14 days after travel to or residence in Provincetown between July 3rd and July 17th, 2021. The majority of specimens in the present dataset were collected through mobile testing deployed in Provincetown by the MADPH following identification of the outbreak (Brown et al., 2021). Cases analyzed in this study ranged in age from 0 to 105 years old; 125 were female and 513 were male. Among cases with genome sequencing information, the age range was the same as for all patients and included 94 females and 373 males.

Cases that did not meet the above criteria as primary cases but were collected in Provincetown or had an epidemiologically confirmed link to a primary case (i.e., secondary cases) are collectively referred to here as “outbreak-associated.” COVID-19 vaccine breakthrough cases were defined on the basis of either i) documentation from the state immunization registry of completion of COVID-19 vaccination as recommended by the CDC Advisory Committee on Immunization Practices ≥14 days before specimen collection or ii) self-reported vaccination dose(s) indicating completion of COVID-19 vaccination ≥14 days before sample collection during follow-up case investigations. Individuals who had received at least one vaccine dose ≥1 day before sample collection but did not meet these criteria were defined as partially vaccinated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A